Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Clinical Medicine Insights. Endocrinology and Diabetes|July 25, 2026
Predictors and Mortality Determinants of Non-Thyroidal Illness Syndrome Among Patients in the Medical Intensive Care Unit in Northeastern TanzaniaNattasha A Mattaka, Isaack A Lyaruu, Joseph Nangawe, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 4, 2026
CD38 Inhibition Enhances FXR Signaling in Male Rats With Diabetic Steatohepatitis Through SIRT1-Dependent Suppression of NLRP3Rabab S Hamad, Sameh Saber, Abdel-Moneim Hafez Abdel-Moneim, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 1, 2025
Activation of nicotinamide phosphoribosyltransferase protects against unilateral renal ischemia-reperfusion injury via the NAD+/SIRT1/PGC-1α signaling pathway and modulation of NFκB/TNF-α/IL-6Elsayed A Elmorsy, Mostafa M Khodeir, Manal M Kamal, et al.
Life Sciences|August 15, 2024
Modulating the HSP90 control over NFκB/NLRP3/Caspase-1 axis is a new therapeutic target in the management of liver fibrosis: Insights into the role of TAS-116 (Pimitespib)Elsayed A Elmorsy, Sameh Saber, Rabab S Hamad, et al.
Life Sciences|June 7, 2024
Hedgehog signaling mastery: R51211's promise in augmenting the therapeutic efficacy of sorafenibAlexandru Madalin Hasan, Simona Cavalu, Sameh Saber, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 14, 2024
Linagliptin, a DPP-4 inhibitor, activates AMPK/FOXO3a and suppresses NFκB to mitigate the debilitating effects of diethylnitrosamine exposure in rat liver: Novel mechanistic insightsRasha Abdelhady, Osama A Mohammed, Ahmed S Doghish, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 11, 2025
E1231/SR647 protects against unilateral renal ischemia-reperfusion injury by modulating SIRT1/FOXO3 interactions with Nrf2 and NFκB pathwaysSameh Saber, Rabab S Hamad, Elsayed A Elmorsy, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|May 7, 2024
A novel combination therapy targets sonic hedgehog signaling by the dual inhibition of HMG-CoA reductase and HSP90 in rats with non-alcoholic steatohepatitisOsama A Mohammed, Mahmoud E Youssef, Ahmed S Doghish, et al.
Tissue & Cell|June 26, 2026
Interrupting a mitochondrial DNA-driven innate immune circuit attenuates hepatic tissue remodeling and fibrotic architecture in experimental steatohepatitisRabab S Hamad, Sura Akram Mohammed, Waseem Ali Hasan, et al.
Tissue & Cell|July 20, 2026
BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASHRabab S Hamad, Sameh Saber, Elsayed A Elmorsy, et al.
Pageof 26